Second-line treatment for advanced NSCLC without actionable mutations: is immunotherapy the ‘panacea’ for all patients?

Overview of attention for article published in BMC Medicine, February 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

reddit: 1 Redditor

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 55 Mendeley

Summary X Reddit Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 15,475 followers.

Meta-analýza je zásadní nástroj medicíny založené na důkazech. Bez znalosti toho, co se vlastně analyzuje, mohou být výsledky problematické. Více komentář k meta-analýze hodnotící imunoterapii nemalobuněčných plicních karcinomů v @BMCMedicine https://t.co

17 Feb 2018

Reply Repost Favourite

New commentary: Second-line #treatment for advanced NSCLC without actionable #mutations: is #immunotherapy the ‘panacea’ for all patients? https://t.co/g55gA062es

16 Feb 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.